Mar 2024 Detection of NPS in Buprenorphine Samples
Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
Clinical Update
05 Feb Aegis Sciences Corporation Announces Its Adoption of Self-Regulatory Standards for NPS Testing
in
News
NASHVILLE, TN. (February 5, 2024) – Nearly 107,000 Americans died from a drug overdose in 2021, according to the Centers for Disease...
Nov 2023 Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
12 Sep Aegis Further Expands Testing for Novel Psychoactive Substances
in
News
NASHVILLE, TN. (September 12, 2023) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased to announce another...
01 Jul Aegis Selected as UnitedHealthcare Preferred Lab Network Provider
in
News
NASHVILLE, Tenn., July 1, 2023 – Aegis is pleased to announce that following a rigorous review process, it will continue to...
26 Jun The Tip of the Iceberg
in
News
Aegis recent panelist, Ryan S. Alexander, DO, MPH, has released an op-ed where he expresses the need for testing in...